Assignee
ANKH LIFE SCIENCES LTD
IE·23 granted patents·13 pending applications·50 citations·filing 2018–2025
Top patents by PatentIndex Score
36 records- 0197US10744124B2Human therapeutic agentsANKH LIFE SCIENCES LTD·Filed 2019·Granted Aug 18, 2020·8 cites·20 claims
- 0295US10751330B2Human therapeutic agentsANKH LIFE SCIENCES LTD·Filed 2019·Granted Aug 25, 2020·5 cites·24 claims
- 0395US10576067B2Therapeutic compositions containing harmine and isovanillin components, and methods of use thereofANKH LIFE SCIENCES LTD·Filed 2019·Granted Mar 3, 2020·5 cites·7 claims
- 0494US10532043B2Therapeutic compositions containing harmine and isovanillin components, and methods of use thereofANKH LIFE SCIENCES LTD·Filed 2019·Granted Jan 14, 2020·3 cites·10 claims
- 0593US10507200B1Therapeutics compositions containing harmine and isovanillin components, and methods of use thereofANKH LIFE SCIENCES LTD·Filed 2019·Granted Dec 17, 2019·3 cites·5 claims
- 0693US10471049B2Therapeutic compositions containing harmine and isovanillin components, and methods of use thereofANKH LIFE SCIENCES LTD·Filed 2018·Granted Nov 12, 2019·3 cites·16 claims
- 0788US11266634B2Methods for treating melanoma with human therapeutic agentsANKH LIFE SCIENCES LTD·Filed 2020·Granted Mar 8, 2022·1 cites·7 claims
- 0888US10875859B2Thymoquinone/harmaline and related reaction productsANKH LIFE SCIENCES LTD·Filed 2019·Granted Dec 29, 2020·4 cites·12 claims
- 0987US11358963B2Low-temperature synthesis of thymoquinone and harmaline compoundsANKH LIFE SCIENCES LTD·Filed 2020·Granted Jun 14, 2022·2 cites·11 claims
- 1086US12129265B2Therapeutic agents and uses thereofANKH LIFE SCIENCES LTD·Filed 2020·Granted Oct 29, 2024·1 cites·7 claims
- 1184US10947253B2Fused polycyclic dimersANKH LIFE SCIENCES LTD·Filed 2019·Granted Mar 16, 2021·6 cites·15 claims
- 1283US12053440B2Inhibition of COVID-19 virus by formulations containing curcumin, harmine, and isovanillinANKH LIFE SCIENCES LTD·Filed 2021·Granted Aug 6, 2024·1 cites·21 claims
- 1382US11951099B2Methods for treating plasma cell neoplasm with human therapeutic agentsANKH LIFE SCIENCES LTD·Filed 2022·Granted Apr 9, 2024·0 cites·8 claims
- 1482US11453664B2Thymoquinone/harmaline and related reaction productsANKH LIFE SCIENCES LTD·Filed 2019·Granted Sep 27, 2022·2 cites·8 claims
- 1582US11453665B2Thymoquinone/harmaline and related reaction productsANKH LIFE SCIENCES LTD·Filed 2019·Granted Sep 27, 2022·2 cites·9 claims
- 1679US10772347B2Nutritional supplementANKH LIFE SCIENCES LTD·Filed 2018·Granted Sep 15, 2020·1 cites·14 claims
- 1778US11576902B2Inhibition of COVID-19 virusANKH LIFE SCIENCES LTD·Filed 2020·Granted Feb 14, 2023·1 cites·8 claims
- 1877US11452715B2Thymoquinone/harmaline and related reaction productsANKH LIFE SCIENCES LTD·Filed 2019·Granted Sep 27, 2022·2 cites·10 claims
- 1976US2024285592A1Human therapeutic agentsANKH LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 2074US2025059209A1Therapeutic agents and uses thereofANKH LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 2169US2019269166A1Nutritional supplementANKH LIFE SCIENCES LTD·Filed 2019·Application pending·0 cites
- 2267US2024390294A1Inhibition of covid-19 virus by multiple-component formulationsANKH LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 2366US2025255853A1Human therapeutic agentsANKH LIFE SCIENCES LTD·Filed 2025·Application pending·0 cites
- 2463US2023000795A1Lipid crystalline compositions with enhanced stability for topical delivery of active agent combinationsANKH LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
- 2562US12419872B2Low-temperature synthesis of thymoquinone and harmaline compoundsANKH LIFE SCIENCES LTD·Filed 2022·Granted Sep 23, 2025·0 cites·11 claims
- 2659US11603343B2Inhibition of DYRK1A kinaseANKH LIFE SCIENCES LTD·Filed 2021·Granted Mar 14, 2023·0 cites·21 claims
- 2759US11578070B2Harmine synthesisANKH LIFE SCIENCES LTD·Filed 2020·Granted Feb 14, 2023·0 cites·11 claims
- 2857US11484492B2Topical medicamentsANKH LIFE SCIENCES LTD·Filed 2020·Granted Nov 1, 2022·0 cites·10 claims
- 2957US11246902B2Nutritional supplement for mammalsANKH LIFE SCIENCES LTD·Filed 2019·Granted Feb 15, 2022·0 cites·9 claims
- 3057US2024092780A1Adducts and dimer compounds synthesized using gk methodANKH LIFE SCIENCES LTD·Filed 2023·Application pending·0 cites
- 3156US2025186367A1Lipid crystalline compositions with enhanced stability for topical delivery of active agent combinationsANKH LIFE SCIENCES LTD·Filed 2025·Application pending·0 cites
- 3256US2024002405A1Antimicrobial compounds, synthesis methods, and uses thereofANKH LIFE SCIENCES LTD·Filed 2023·Application pending·0 cites
- 3354US2022008359A1Combination anti-cancer products and methodsANKH LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 3452US2022175869A1FORMULATIONS INHIBITING SARS-CoV-2 VIRUSANKH LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 3552US2022175868A1INHIBITION OF SARS-CoV-2 VIRUS BY ARUM PALAESTINUMANKH LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 3650US2022175769A1Method of treatment of actinic keratosesANKH LIFE SCIENCES LTD·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →